Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 5/2000

01-05-2000

Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma

Authors: Kenji Ikeda, Satoshi Saitoh, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Akihito Tsubota, Yasuji Arase, Kazuaki Chayama, Naoya Murashima, Hiromitsu Kumada

Published in: Journal of Gastroenterology | Issue 5/2000

Login to get access
Metadata
Title
Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
Authors
Kenji Ikeda
Satoshi Saitoh
Masahiro Kobayashi
Yoshiyuki Suzuki
Fumitaka Suzuki
Akihito Tsubota
Yasuji Arase
Kazuaki Chayama
Naoya Murashima
Hiromitsu Kumada
Publication date
01-05-2000
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 5/2000
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350050360

Other articles of this Issue 5/2000

Journal of Gastroenterology 5/2000 Go to the issue

Editorial

How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma?

OriginalPaper

Taurine preserves gap junctional intercellular communication in rat hepatocytes under oxidative stress

Case report

Non-traumatic gas gangrene in the abdomen: report of six autopsy cases

Case report

Lymphoepithelial cyst of the pancreas with sebaceous differentiation

OriginalPaper

Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats

OriginalPaper

Influence of Helicobacter pylori infection on development of stress-induced gastric mucosal injury
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits